Fiche centre
University of Illinois at Chicago
Chicago — United States
Essais liés4clinical trials
VilleChicagolocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05739383
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL | Maladie coronarienne | Phase 3 | NCT05739383 | A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. | ACTIVE_NOT_RECRUITING |
| Analysis of Human ALS Tissues and Registry of ALS Patients | Sclérose latérale amyotrophique | À vérifier | NCT05067179 | Analysis of Human ALS Tissues and Registry of ALS Patients | RECRUITING |
| FERLAMS — Feasibility of Remote Exercise Training for Hispanics/Latinos With MS | SEP | Non applicable | NCT05998616 | FERLAMS — Feasibility of Remote Exercise Training for Hispanics/Latinos With MS | TERMINATED |
| METS in MS — Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis | SEP | NA | NCT05051618 | METS in MS — Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis | RECRUITING |